Cargando...
Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy
Chimeric antigen receptor (CAR) T-cell therapy engineers T-cells to express a synthetic receptor which redirects effector function to the tumor, to improve efficacy and reduce toxicities associated with conventional treatments, such as radiotherapy and chemotherapy. This approach has proved effectiv...
Gardado en:
| Publicado en: | Biologics |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8053711/ https://ncbi.nlm.nih.gov/pubmed/33883875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S291768 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|